/INMD
INMD Stock - InMode Ltd.
Healthcare|Medical - DevicesNASDAQ
$14.36-1.37%
$0.20 (-1.37%) • Dec 19
48
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.41
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).59
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.34
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+4.5%upside
Target: $15.01
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for INMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$14.22 – $14.50
TARGET (TP)$15.00
STOP LOSS$13.21
RISK/REWARD1:0.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.15
52W High$19.78
52W Low$13.14
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $394.82M | $492.05M | $454.27M | $357.56M | $206.11M |
| Gross Profit | $317.07M | $411.34M | $380.79M | $303.97M | $175.26M |
| Gross Margin | 80.3% | 83.6% | 83.8% | 85.0% | 85.0% |
| Operating Income | $112.53M | $195.66M | $197.85M | $167.48M | $72.84M |
| Net Income | $181.28M | $197.92M | $161.52M | $164.97M | $75.03M |
| Net Margin | 45.9% | 40.2% | 35.6% | 46.1% | 36.4% |
| EPS | $2.29 | $2.37 | $1.96 | $2.03 | $1.04 |
Company Overview
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
33%
Hold / Neutral
6
67%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
3 Bullish6 Neutral/Bearish
Price Targets
$29
Average Target
↑ 100.2% Upside
Now
$16
Low
$29
Average
$44
High
Based on 8 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| April 29th 2025 | BTIG Research | Downgrade | Neutral | - |
| April 28th 2025 | Robert W. Baird | Downgrade | Neutral | $16← $22 |
| October 17th 2024 | BTIG Research | Initiation | Buy | $25 |
| July 23rd 2024 | Jefferies | Downgrade | Hold | $19← $21 |
| November 3rd 2023 | UBS | Downgrade | Neutral | $24← $52 |
| October 13th 2023 | Canaccord Genuity | Downgrade | Hold | $22← $55 |
| March 29th 2023 | UBS | Initiation | Buy | $40 |
| February 17th 2023 | Needham | Downgrade | Hold | - |
| December 21st 2022 | Barclays | Initiation | Overweight | $44 |
| October 12th 2022 | Jefferies | Initiation | Buy | $40 |
Earnings History & Surprises
INMDBeat Rate
72%
Last 18 quarters
Avg Surprise
+4.5%
EPS vs Estimate
Beats / Misses
13/5
Last 12 quarters
Latest EPS
$0.38
Q4 2025
EPS Surprise History
Q1 24
+6.0%
$0.71vs$0.67
Q2 24
-22.0%
$0.32vs$0.41
Q3 24
-10.5%
$0.34vs$0.38
Q4 24
+11.1%
$0.70vs$0.63
Q1 25
-16.0%
$0.42vs$0.50
Q2 25
-6.1%
$0.31vs$0.33
Q3 25
+9.3%
$0.47vs$0.43
Q4 25
+8.3%
$0.38vs$0.35
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 4, 2026 | $0.42 | — | — | — |
Q4 2025 | Nov 5, 2025 | $0.35 | $0.38 | +8.3% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $0.43 | $0.47 | +9.3% | ✓ BEAT |
Q2 2025 | Apr 28, 2025 | $0.33 | $0.31 | -6.1% | ✗ MISS |
Q1 2025 | Feb 4, 2025 | $0.50 | $0.42 | -16.0% | ✗ MISS |
Q4 2024 | Oct 30, 2024 | $0.63 | $0.70 | +11.1% | ✓ BEAT |
Q3 2024 | Aug 1, 2024 | $0.38 | $0.34 | -10.5% | ✗ MISS |
Q2 2024 | May 2, 2024 | $0.41 | $0.32 | -22.0% | ✗ MISS |
Q1 2024 | Feb 13, 2024 | $0.67 | $0.71 | +6.0% | ✓ BEAT |
Q4 2023 | Nov 2, 2023 | $0.64 | $0.61 | -4.7% | ✗ MISS |
Q3 2023 | Jul 27, 2023 | $0.64 | $0.72 | +12.5% | ✓ BEAT |
Q2 2023 | May 2, 2023 | $0.47 | $0.52 | +10.6% | ✓ BEAT |
Q1 2023 | Feb 14, 2023 | $0.74 | $0.78 | +5.4% | ✓ BEAT |
Q4 2022 | Oct 27, 2022 | $0.58 | $0.66 | +13.8% | ✓ BEAT |
Q3 2022 | Jul 28, 2022 | $0.51 | $0.59 | +15.7% | ✓ BEAT |
Q2 2022 | May 2, 2022 | $0.38 | $0.40 | +5.3% | ✓ BEAT |
Q1 2022 | Feb 10, 2022 | $0.56 | $0.64 | +14.3% | ✓ BEAT |
Q4 2021 | Oct 26, 2021 | $0.50 | $0.55 | +10.0% | ✓ BEAT |
Q3 2021 | Jul 28, 2021 | $0.43 | $0.51 | +18.6% | ✓ BEAT |
Latest News
Canaccord Genuity Maintains Hold on InMode, Lowers Price Target to $15
📉 NegativeBenzinga•Dec 17, 2025, 07:53 PM•Also:
UBS Maintains Neutral on InMode, Lowers Price Target to $16
➖ NeutralBenzinga•Nov 6, 2025, 06:45 PM
InMode Affirms FY2025 Sales Guidance of $365.000M-$375.000M vs $371.511M Est
➖ NeutralBenzinga•Nov 5, 2025, 12:09 PM
InMode Q3 Adj. EPS $0.38 Beats $0.35 Estimate, Sales $93.165M Beat $88.349M Estimate
📈 PositiveBenzinga•Nov 5, 2025, 12:08 PM
The U.S. FDA Is Making Consumers, Patients, And Health Care Providers Aware That Serious Complications Have Been Reported With Certain Uses Of Radiofrequency Microneedling Devices
📉 NegativeBenzinga•Oct 15, 2025, 03:10 PM•Also:
Canaccord Genuity Maintains Hold on InMode, Raises Price Target to $16
➖ NeutralBenzinga•Oct 10, 2025, 12:47 PM•Also:
Needham Reiterates Hold on InModeto Hold
➖ NeutralBenzinga•Oct 10, 2025, 10:08 AM
InMode shares are trading higher after the company reported Q3 sales guidance above estimates.
📈 PositiveBenzinga•Oct 9, 2025, 12:56 PM
InMode Affirms FY2025 Sales Guidance of $365.000M-$375.000M vs $370.991M Est
➖ NeutralBenzinga•Oct 9, 2025, 11:20 AM
InMode Sees Q3 Sales $92.500M-$93.000M vs $85.873M Est
📈 PositiveBenzinga•Oct 9, 2025, 11:20 AM
DOMA Perpetual Capital Management Urges InMode Board To Approve Two 10% Buybacks In Q4 2025 And Q1 2026, Citing Duty To Return Capital To Shareholders
📈 PositiveBenzinga•Sep 9, 2025, 12:20 PM•Also:
InMode slides on full year profit guidance cut
📉 NegativeSeeking Alpha•Apr 28, 2025, 06:01 PM
Frequently Asked Questions about INMD
What is INMD's current stock price?
InMode Ltd. (INMD) is currently trading at $14.36 per share. The stock has moved -1.37% today.
What is the analyst price target for INMD?
The average analyst price target for INMD is $15.00, based on 1 analyst.
What sector is InMode Ltd. in?
InMode Ltd. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is INMD's market cap?
InMode Ltd. has a market capitalization of $0.96 billion, making it a small-cap company.
Does INMD pay dividends?
No, InMode Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAHCO
AdaptHealth Corp.
$9.97
Mkt Cap: $1.4B
ANAB
AnaptysBio, Inc.
$49.08
Mkt Cap: $1.4B
AXGN
AxoGen, Inc.
$31.98
Mkt Cap: $1.5B
CTEV
Claritev Corporation
$41.02
Mkt Cap: $0.7B
IART
Integra LifeSciences Holdings Corporation
$12.65
Mkt Cap: $1.0B
IRMD
IRadimed Corporation
$97.19
Mkt Cap: $1.2B
OCS
Oculis Holding AG
$21.25
Mkt Cap: $1.1B
OPK
OPKO Health, Inc.
$1.31
Mkt Cap: $1.0B
TNDM
Tandem Diabetes Care, Inc.
$22.07
Mkt Cap: $1.5B
XNCR
Xencor, Inc.
$15.55
Mkt Cap: $1.1B
Explore stocks similar to INMD for comparison